TrialNature communications2026

HRS-7535, an oral small-molecule GLP-1 receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial.

Weijun Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.